NANCY BERG NAMED ONE OF 2016 PM360 ELITE 100

Published Jun 6, 2016
ISPOR CEO Honored as a Transformational Leader  Princeton, NJ—June 6, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today that CEO and Executive Director Nancy Berg has been recognized as a transformational leader by PM360’s annual ELITE award program. The PM360 ELITE (Exceptional – Leaders – Innovators – Transformers – Entrepreneurs) awards recognize the most influential people in the health care industry today. PM360 is a leading health-marketing industry trade magazine and information resource. The PM360 ELITE Awards were established in 2015 to recognize individuals who have made a significant impact to the health care industry throughout their careers. In 2014, Berg assumed the role of CEO and Executive Director of ISPOR, the leading global scientific and educational organization for health economics and outcomes research (HEOR). In partnership with the ISPOR Board of Directors, Ms. Berg designed and implemented a new strategic plan, mission, and vision that will guide the Society into the future. Prior to joining ISPOR, Berg served as President and CEO of the International Society for Pharmaceutical Engineering (ISPE). Berg’s PM360 ELITE profile article can be viewed here. “Each of the 100 individuals and teams selected truly demonstrated that they have left their mark on this industry,” says Anna Stashower, CEO and Publisher of PM360. “Whether it was from a career worth of accomplishments or a single initiative that changed how things are done, each of them is deserving of being called ELITE.” “I am so honored to be named a PM360 ELITE,” noted Nancy Berg. “The Society’s members and global leaders play a critical role in bringing research excellence into the everyday health care decisions that impact patients’ lives. It is such a privilege to serve as ISPOR’s CEO at a time when the importance of HEOR in health care has never been greater.” Berg and the rest of the PM360 ELITE winners will be honored at a celebratory event on July 12th in New York City at the Top of The Standard rooftop bar. Tickets for the event are available here.

###

Related Stories

ISPOR Announces New Strategic Plan 2030

Jul 29, 2024

ISPOR announced its new Strategic Plan 2030 that presents a bold new vision for the Society and the field of health economics and outcomes research (HEOR).

Measuring What Matters: Broadening the Scope of Health Economics Evaluation to Incorporate Well-Being

Jul 9, 2024

ISPOR announced the publication of a special themed section of research papers in Value in Health that offer insights into facets of economic evaluation aimed to incorporate well-being into decision making.

Confronting the Backlash Against QALYs: Key Insights From Leading Health Economists

Jun 18, 2024

ISPOR announced the publication of a collection of papers that examine the long-standing debate surrounding the use of quality-adjusted life years (QALYs) and alternative measures in healthcare decision making.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×